Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|May 21, 2016
Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral ControlMegan M Tu, Ahmad Bakur Mahmoud, Andrew P MakrigiannisCurrent Opinion in Microbiology|November 27, 2024
Important challenges to finding new leads for new antibioticsMaya A Farha, Megan M Tu, Eric D BrownCancer Immunology Research|September 20, 2017
Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC ReceptorsMegan M Tu, Mir Munir A Rahim, Céline Sayed, et al.Cell Reports Methods|January 23, 2024
A mobile CRISPRi collection enables genetic interaction studies for the essential genes of Escherichia coliKenneth Rachwalski, Megan M Tu, Sean J Madden, et al.Placenta|March 20, 2016
Ly49 knockdown in mice results in aberrant uterine crypt formation and impaired blastocyst implantationLucy Leon, Allison M Felker, Vanessa R Kay, et al.Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
Critical role for the Ly49 family of class I MHC receptors in adaptive natural killer cell responsesAndrew Wight, Ahmad Bakur Mahmoud, Michal Scur, et al.Bladder Cancer (Amsterdam, Netherlands)|December 28, 2020
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerMegan M Tu, Terry L Ng, Florus C De Jong, et al.Cellular & Molecular Immunology|June 24, 2014
Ly49 receptors activate angiogenic mouse DBA⁺ uterine natural killer cellsPatricia D A Lima, Megan M Tu, Mir Munir A Rahim, et al.Frontiers in Immunology|April 26, 2014
Ly49 receptors: innate and adaptive immune paradigmsMir Munir A Rahim, Megan M Tu, Ahmad Bakur Mahmoud, et al.Cancer Research|May 8, 2014
Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cellsMegan M Tu, Ahmad Bakur Mahmoud, Andrew Wight, et al.Pageof 4